Biome Australia Ltd has released a press release.
FY22 Revenue Guidance
Filed with ASX ·
Watch Biome Australia's latest callBiome Australia (ASX:BIO) Q1 2026 Earnings Call · Replay · Oct 22, 2025Read the transcript of Biome Australia (ASX:BIO) Q1 2026 Earnings Call6ix hasn’t read this filing yet.
Earlier from Biome Australia
- Biome signs distribution agreement with Priceline Pharmacy
- FY22 Trading Update
- Record H1 sales deliver 98% revenue growth
- Appendix 4D and Half Yearly Report
- Ethics approval received for Biome Daily Kids clinical trial
Later from Biome Australia
- Delivery of Activated Probiotics to 370 Priceline Pharmacies
- Biome Lift Clinical Trial Hits Recruitment Target
- FY23 Trading Update
- FY22 Company Presentation
- FY23 Q1 Sales Revenue Update and FY23 Forecast
Follow Biome Australia into a list and get an email when it puts out news.
Follow Biome Australia